top headlines
The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for [...]
Medable has launched a new support programme aimed at helping [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Sapio Sciences has partnered with consulting and technology firm ZS [...]
Chiesi Global Rare Diseases has launched the second edition of [...]
Lonza has expanded its integrated DNA-to-IND biologics development offering, introducing [...]
AstraZeneca is presenting a broad package of new clinical and [...]
The Society for RNA Therapeutics (SRT) has expanded its leadership [...]
CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]
